Signatera™ MRD Outperformed AMERK Testing in Predicting Merkel Cell Carcinoma Recurrence in JAMA Dermatology Study | NTRA Stock NewsStockTitan·Jul 21 at 09:00 PMNTRA-1.02%
Tempus AI Makes Billion-Dollar Bet on the Future of Cancer Monitoringbenzinga_article·Jul 21 at 01:52 PMTEM-7.22%PSNL-3.60%
Natera co-founder, Director Sheena Jonathan disposes of 1,500 common shares worth $410,322.91PUBT·Jul 17 at 08:05 PMNTRA-1.02%
Finalized MolDx LCD Includes Expanded Coverage for Natera’s Prospera™ Portfolio | NTRA Stock NewsStockTitan·Jul 16 at 09:35 AMNTRA-1.02%
Billionaire Stanley Druckenmiller's top holding isn't Nvidia. Instead, it's this under-the-radar stock that Wall Street loves.MSN·Jul 16 at 08:11 AMNTRA-1.02%NVDA-0.92%
Natera co-founder, director Sheena Jonathan sells 3,150 shares worth $835,835.18PUBT·Jul 15 at 08:05 PMNTRA-1.02%
Krystal Biotech Stock And 2 Biotech Names With Pipeline CatalystsSimplywall·Jul 13 at 12:03 AMKRYS+2.35%NTRA-1.02%
Is Natera (NTRA) Fully Valued As Signatera Wins EU IVDR Certification?Simplywall·Jul 10 at 04:12 PMNTRA-1.02%
Natera Announces IVDR Certification for Signatera™ Across Multiple Cancers | NTRA Stock NewsStockTitan·Jul 8 at 09:00 PMNTRA-1.02%
